Development of a Mercaptopurine method
Posted: Tue Nov 11, 2008 9:47 pm
We are trying to develop a method for measuring mercaptopurine in a suspension prepared with the USP Vehicle for Oral Suspension. This vehicle contains microcrystalline cellulose, xanthan gum, carrageenan, carboxymethylcellulose sodium, citric acid, sodium phosphate dibasic, simethicone, potassium sorbate, methylparaben, and water. We started out with the USP HPLC method which uses a C18 column with a ACN/ 0.1% AcOH in water gradient. We found that if we use any ACN, our compound co-elutes with the DMSO in the solvent front. Also we found that we needed to drop the pH to improve the mercaptopurine peak shape so now we are running just pH 2 phosphate buffer. (pKa ~ 3.7)
We've tried injecting mercaptopurine standards in DMSO and in the suspension vehicle. The mercaptopurine peak in just DMSO elutes around 4 minutes. The mercaptopurine peak in the suspension elutes at about 6 minutes. I am wondering if something in the vehicle is complexing the mercaptopurine, causing it to be less polar and elute later.
I have two questions. Is there a different column that I should be using so that this compound is better retained and I can add some organic to the mobile phase? How can I prepare my samples so that the suspension vehicle does not cause a peak shift.
Thanks very much for any suggestions.
KarenJ
We've tried injecting mercaptopurine standards in DMSO and in the suspension vehicle. The mercaptopurine peak in just DMSO elutes around 4 minutes. The mercaptopurine peak in the suspension elutes at about 6 minutes. I am wondering if something in the vehicle is complexing the mercaptopurine, causing it to be less polar and elute later.
I have two questions. Is there a different column that I should be using so that this compound is better retained and I can add some organic to the mobile phase? How can I prepare my samples so that the suspension vehicle does not cause a peak shift.
Thanks very much for any suggestions.
KarenJ